We would like to thank our exhibitors and sponsors for sponsoring this meeting. This includes pharmaceutical companies including AstraZeneca UK. They have had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the sponsored symposia presentations.

10 CPD hours

Tuesday, February 4, 2025
9:35 AM - 10:25 AM
Chair’s opening remarks followed by: Atrial fibrillation: diagnosis and management—summary of NICE guidance

 

  • The importance of comorbidities in development and burden of atrial fibrillation
  • Who to offer anticoagulation possible pitfalls
  • When to consider rhythm control strategy 
 
 
 
10:40 AM - 11:25 AM
See beyond sugar: uncovering risk in type 2 diabetes

 

 

This is a promotional symposium sponsored and organised by AstraZeneca, intended for UK HCPs only
See beyond sugar: uncovering risk in type 2 diabetes
 
11:40 AM - 12:25 PM
Enabling optimised cardiorenal risk management in primary care
 
This is a promotional symposium sponsored and organised by AstraZeneca, intended for UK HCPs only
Enabling optimised cardiorenal risk management in primary care
 
12:40 PM - 1:25 PM
Practical applications of lifestyle medicine in primary care
 
 
 
 
1:40 PM - 2:25 PM
Obstructive sleep apnoea – a general practice approach

 

  • Disorders of sleep
  • Risks for OSA
  • When to suspect OSAHS, case finding 
 
 
 
2:40 PM - 3:25 PM
A simple guide to ECG interpretation – getting it right every time
 
 
 
 
3:40 PM - 4:25 PM
Managing lipids and FH in primary care

 

  • Family screening and genetic counselling in primary care
  • Lifestyle changes and pharmacological interventions
  • Lipid level monitoring and long-term care
 
 
 
4:25 PM
Conference ends
 
 
 
 
 
Wednesday, February 5, 2025
9:30 AM - 10:25 AM
Implementing the updated BTS, NICE, SIGN asthma guideline in clinical practice

 

  • The Impact of SABA over reliance
  • Treatment Guidelines
  • Managing Asthma patients: putting evidence into practice
     
This is a promotional symposium sponsored and organised by AstraZeneca, intended for UK HCPs only
Implementing the updated BTS, NICE, SIGN asthma guideline in clinical practice
 
10:40 AM - 11:25 AM
COPD patient care: opportunities to improve disease trajectory

 

  • COPD burden and the risk of premature mortality
  • Uncontrolled COPD may increase the risk of cardiopulmonary events
  • Exacerbations as the driving force of poor outcomes in COPD
     
This is a promotional symposium sponsored and organised by AstraZeneca, intended for UK HCPs only
COPD patient care: opportunities to improve disease trajectory
 
11:40 AM - 12:25 PM
Delivering effective, drug-free airways clearance in primary care

 

  • Understand the impact that excessive airway mucus secretions have on COPD patients
  • The benefits non-pharmacological interventions such as Oscillating Positive Expiratory Pressure (OPEP) devices can offer in COPD
  • Access to tools and services to support Airway Clearance in Primary Care
     
Sponsored by
Delivering effective, drug-free airways clearance in primary care
 
12:40 PM - 1:25 PM
What to do with the breathless patient

 

  • When to admit
  • What tests should I do?
  • What should I be looking out for?
 
 
 
1:40 PM - 2:25 PM
Respiratory palliative care: approaches, challenges and best practices

 

  • How to define
  • How to assess
  • How to manage
 
 
 
2:40 PM - 3:25 PM
The Sleeping Giant: Type 2 Diabetes and Obstructive Sleep Apnoea

 

  • Importance of duration and quality of sleep
  • Diagnosis and management of OSAHS in primary care
  • The bidirectional association of T2D and OSAHS
 
 
 
3:40 PM - 4:25 PM
Diagnosing cystic fibrosis in adults

 

  • A refresher on the basic CF defect
  • The late CF diagnosis
  • An update on CF in 2025
 
 
 
4:25 PM
Conference ends
 
 
 
 
 

Speakers